30 Apr 2026 ยท NGX
Interim
QUARTER 1 - FINANCIAL STATEMENT FOR 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC
Read filing โ| Date | Close | Change | Chg % | Volume |
|---|---|---|---|---|
| 5 May 2026, 16:00 GMT+1 | โฆ8.15 | +0.05 | +0.62% | 5.02M |
| 4 May 2026, 16:00 GMT+1 | โฆ8.10 | -0.20 | -2.41% | 3.14M |
| 1 May 2026, 16:00 GMT+1 | โฆ8.30 | -0.65 | -7.26% | 2.78M |
| 30 Apr 2026, 16:00 GMT+1 | โฆ8.30 | -0.65 | -7.26% | 2.78M |
| 29 Apr 2026, 16:00 GMT+1 | โฆ8.90 | -0.35 | -3.78% | 3.53M |
| 28 Apr 2026, 16:00 GMT+1 | โฆ9.25 | +0.25 | +2.78% | 737.2K |
| 27 Apr 2026, 16:00 GMT+1 | โฆ9.00 | -0.55 | -5.76% | 1.16M |
Neimeth International Pharmaceuticals Plc (NEIMETH) is listed on the Nigerian Exchange and trades in NGN (โฆ). The company operates in the HEALTHCARE sector. Current market capitalisation stands at โฆ34.83B. Data on Mansa Markets refreshes every 30 minutes during NGX trading hours (09:30โ14:30 Lagos).
| Ex-Dividend Date | Cash Amount | Record Date | Pay Date |
|---|---|---|---|
| 15 Mar 2022 | 0.07 NGN | 14 Mar 2022 | 25 Mar 2022 |
| 23 Feb 2021 | 0.065 NGN | 22 Feb 2021 | 12 Mar 2021 |